Matrix metalloproteinase-2 and matrix metalloproteinase-9 type IV collagenases in serum of patients with pleural effusions
- PMID: 15809729
Matrix metalloproteinase-2 and matrix metalloproteinase-9 type IV collagenases in serum of patients with pleural effusions
Abstract
Matrix metalloproteinases (MMPs) are proteolytic enzymes that are essentially involved in the turnover of the extracellular matrix (ECM). Recently, several MMPs were implicated in creating an environment that supports the initiation and maintenance of tumor growth. We verified MMP activity in the sera of patients with pleural effusions by gelatin zymography. Of these patients, 22 had malignant pleural effusion, consisting of 11 breast carcinomas and 11 lung carcinomas (7 squamous cell carcinomas and 4 adenocarcinomas), and 8 patients had benign effusions. The sera of 25 healthy subjects were used as controls. Zymography analysis showed three major gelatinolytic bands of 72, 92 and 220 kDa. The MMP-9/MMP-2 ratio was enhanced in cancer patients compared with benign diseases and healthy individuals. Furthermore, we determined the circulating levels of carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (Ca 19-9), carbohydrate antigen 15-3 (Ca 15-3). The serum levels of Ca 15-3 were above the cut-off levels in several cancer patients. No correlation between gelatinolytic activity and high tumoral marker values was found.
Similar articles
-
Gelatinolytic activities (matrix metalloproteinase-2 and -9) and soluble extracellular domain of Her-2/neu in pleural effusions.Oncol Rep. 2007 Aug;18(2):425-31. Oncol Rep. 2007. PMID: 17611666
-
Elevated level of circulating matrix metalloproteinase-9 in patients with lung cancer.Respir Med. 2001 Jan;95(1):1-4. doi: 10.1053/rmed.2000.0923. Respir Med. 2001. PMID: 11207010
-
[Zymography--method for quantitation of activity on gelatinase A (pro-MMP-2, 72 kDa) and gelatinase B (pro-MMP-9, 92 kDa) in serum of patients with breast cancer].Wiad Lek. 2007;60(5-6):241-7. Wiad Lek. 2007. PMID: 17966888 Polish.
-
Creatine kinase isoenzyme 1.Clin Lab Med. 1982 Sep;2(3):493-506. Clin Lab Med. 1982. PMID: 6754222 Review. No abstract available.
-
Zinc and metalloproteinases 2 and 9: What is their relation with breast cancer?Rev Assoc Med Bras (1992). 2017 Jan 1;63(1):78-84. doi: 10.1590/1806-9282.63.01.78. Rev Assoc Med Bras (1992). 2017. PMID: 28225881 Review.
Cited by
-
IIICS de novo glycosylated fibronectin as a marker for invasiveness in urothelial carcinoma of the urinary bladder (UBC).J Cancer Res Clin Oncol. 2008 Oct;134(10):1059-65. doi: 10.1007/s00432-008-0390-6. Epub 2008 Apr 3. J Cancer Res Clin Oncol. 2008. PMID: 18386055 Free PMC article.
-
Pleural fluid analysis of lung cancer vs benign inflammatory disease patients.Br J Cancer. 2010 Mar 30;102(7):1180-4. doi: 10.1038/sj.bjc.6605607. Epub 2010 Mar 9. Br J Cancer. 2010. PMID: 20216542 Free PMC article.
-
Plasma levels of matrix metalloproteinases 2 and 9 correlate with histological grade in breast cancer patients.Oncol Lett. 2013 Jan;5(1):316-320. doi: 10.3892/ol.2012.977. Epub 2012 Oct 17. Oncol Lett. 2013. PMID: 23255941 Free PMC article.
-
NF‑κB inhibition is associated with OPN/MMP‑9 downregulation in cutaneous melanoma.Oncol Rep. 2017 Feb;37(2):737-746. doi: 10.3892/or.2017.5362. Epub 2017 Jan 10. Oncol Rep. 2017. PMID: 28075446 Free PMC article.
-
Pinosylvin inhibits migration and invasion of nasopharyngeal carcinoma cancer cells via regulation of epithelial‑mesenchymal transition and inhibition of MMP‑2.Oncol Rep. 2021 Jul;46(1):143. doi: 10.3892/or.2021.8094. Epub 2021 Jun 3. Oncol Rep. 2021. PMID: 34080661 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials